Clinical Observation of PD-1/PD-L1 Inhibitors Combined with Anti Angiogenic Drugs in the Treatment of Advanced/Unresectable Chronic Hepatitis B Related Hepatocellular Carcinoma Patients
-
Published:2024
Issue:05
Volume:14
Page:2613-2626
-
ISSN:2161-8712
-
Container-title:Advances in Clinical Medicine
-
language:
-
Short-container-title:ACM
Publisher
Hans Publishers
Reference22 articles.
1. Cancer statistics in China and United States, 2022: profiles, trends, and determinants
2. Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice
3. Hepatocellular carcinoma
4. Multidrug resistance gene (MDR-1) expression as a useful prognostic factor in patients with human hepatocellular carcinoma after surgical resection
5. Jiang, W., Lu, Z., He, Y., et al. (1997) Dihydropyrimidine Dehydrogenase Activity in Hepatocellular Carcinoma: Implication in 5-Fluorouracil-Based Chemotherapy. Clinical Cancer Research, 3, 395-399.